 | TransCode Therapeutics, Inc. | |||
| NCM : RNAZ || Location: United States | ||||
$0.55+0.03 (+4.76%) |
0.71 M | 0.5 - 0.58 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.019 M |
| March 28, 2024 | 0.040 M |
| March 15, 2024 | 0.175 M |
| Feb. 29, 2024 | 0.102 M |
| Feb. 15, 2024 | 0.221 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -11.02 | -22.84 | -107.33% |
| 09/30/2023 | -61.20 | -67.20 | -9.80% |
| 06/30/2023 | -138.31 | -131.60 | 4.85% |
| 12/31/2022 | -7.60 | -8.00 | -5.30% |
| 09/30/2022 | -8.16 | -6.60 | 19.12% |
RNAZ Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 5.808M | Shares Float | 5.806M |
| Short Float | 0.019M | Market Cap | 3.02M |
| Institution ownership | 0.31% | Insider ownership | 0.146% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -4144.40 | Forward EPS | -0.67 |